Information  X 
Enter a valid email address

Indivior Plc Ord USD0.10 (INDV)

Date Time Source Announcement
24 May 2018 7:00 am
RNS
Indivior Participating in Jefferies NYC Conference
16 May 2018 5:50 pm
RNS
Result of AGM
14 May 2018 7:00 am
RNS
Indivior settlement with Par Pharmaceutical
10 May 2018 11:40 am
RNS
Block listing Interim Review
04 May 2018 2:13 pm
RNS
Director/PDMR Shareholding
02 May 2018 7:00 am
RNS
1st Quarter Results
20 Apr 2018 7:00 am
RNS
Indivior's SUBLOCADE NDS Accepted by Health Canada
12 Apr 2018 3:56 pm
RNS
Holding(s) in Company
11 Apr 2018 4:02 pm
RNS
Director Declaration
  7:00 am
RNS
Notice of Results
06 Apr 2018 9:31 am
RNS
Holding(s) in Company
05 Apr 2018 7:00 am
RNS
Indivior Asserts New SUBOXONE(R) Film Patent
04 Apr 2018 9:28 am
RNS
Director/PDMR Shareholding
03 Apr 2018 9:33 am
RNS
Holding(s) in Company
  7:00 am
RNS
Total Voting Rights
29 Mar 2018 7:00 am
RNS
Indivior and C4X Enter Licensing Agreement
27 Mar 2018 4:13 pm
RNS
Holding(s) in Company
23 Mar 2018 7:00 am
RNS
Indivior Responds to Court Ruling ANDA litigation
22 Mar 2018 1:39 pm
RNS
Annual Financial Report
13 Mar 2018 3:14 pm
RNS
Director/PDMR Shareholding
12 Mar 2018 4:30 pm
RNS
Director/PDMR Shareholding
02 Mar 2018 2:51 pm
RNS
Holding(s) in Company
  10:24 am
RNS
Holding(s) in Company
01 Mar 2018 1:00 pm
RNS
Indivior Announces SUBLOCADET Available in US
  7:00 am
RNS
Total Voting Rights
28 Feb 2018 5:45 pm
RNS
Director/PDMR Shareholding
  4:53 pm
RNS
Holding(s) in Company
19 Feb 2018 7:00 am
RNS
Holding(s) in Company
15 Feb 2018 7:00 am
RNS
Final Results
14 Feb 2018 9:50 am
RNS
Holding(s) in Company
12 Feb 2018 3:49 pm
RNS
Holding(s) in Company
08 Feb 2018 3:27 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Indivior asserts new patent against ANDA-filers
06 Feb 2018 2:14 pm
RNS
Holding(s) in Company
01 Feb 2018 7:05 am
RNS
Total Voting Rights
  7:00 am
RNS
Indivior Provides Update on Tax Position
19 Jan 2018 7:00 am
RNS
Notice of Results
08 Jan 2018 9:24 am
RNS
Holding(s) in Company
04 Jan 2018 1:00 pm
RNS
J.P. Morgan Healthcare Conference
03 Jan 2018 7:00 am
RNS
Indivior and Addex Enter Strategic Collaboration
19 Dec 2017 7:00 am
RNS
Indivior amends and extends $534m debt facilities
12 Dec 2017 7:00 am
RNS
Indivior's RBP-7000 NDA Accepted by FDA
08 Dec 2017 7:00 am
RNS
Additional Listing
01 Dec 2017 7:00 am
RNS
FDA Approves SUBLOCADE (TM)
23 Nov 2017 1:46 pm
RNS
Holding(s) in Company
10 Nov 2017 4:02 pm
RNS
Block listing Interim Review
06 Nov 2017 7:00 am
RNS
Jefferies London Healthcare Conference
02 Nov 2017 1:28 pm
RNS
Board Committee Changes
  11:40 am
RNS
Holding(s) in Company
  11:00 am
RNS
3rd Quarter Results
01 Nov 2017 7:00 am
RNS
FDA Advisory Committees Vote to Approve RBP-6000
10 Oct 2017 7:00 am
RNS
Notice of Results
09 Oct 2017 1:17 pm
RNS
Holding(s) in Company
03 Oct 2017 4:00 pm
RNS
FDA Posts Advisory Committee Notice for RBP-6000
02 Oct 2017 7:00 am
RNS
RBP-7000 - Submission of NDA to U.S. FDA
25 Sep 2017 7:00 am
RNS
Indivior settlement with Mylan Pharmaceuticals
21 Sep 2017 3:36 pm
RNS
Holding(s) in Company
  9:37 am
RNS
Holding(s) in Company
15 Sep 2017 7:00 am
RNS
Indivior asserts new patent against ANDA-filers
11 Sep 2017 9:50 am
RNS
Holding(s) in Company
 
Headlines
Top categories

25-May-2018 12:30 PM

Broker Forecast - Liberum Capital issues a broker note on Taylor Wimpey PLC

Liberum Capital today reaffirms its hold investment rating on Taylor Wimpey PLC (LON:TW.) and set its price target at 190p. Story provided by StockMa ...

Company finder

a d v e r t i s e m e n t